| Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without Letermovir | Open forum infectious diseases |  | | 2026 | 3 | 13 |
|
| Soins palliatifs : ne pas attendre la fin de vie | Revue médicale suisse |  | | 2025 | 46 | 0 |
|
| Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes : a validation cohort study | Journal for immunotherapy of cancer | | | 2025 | 3 | 6 |
|
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | | | 2025 | 67 | 134 |
|
| Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality | Bone marrow transplantation | | | 2025 | 9 | 0 |
|
| Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation | | | 2024 | 88 | 0 |
|
| Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia : a case report | Frontiers in immunology | | | 2024 | 44 | 162 |
|
| Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case report | Frontiers in immunology | | | 2024 | 63 | 162 |
|
| Severe anaphylaxis after chimeric antigen receptor T-cell injection : a case report | EJHaem | | | 2024 | 59 | 171 |
|
| Réhabilitation pré, per et post-allogreffe de cellules souches hématopoïétiques (atelier SFGM-TC) | Bulletin du cancer | | | 2024 | 102 | 0 |
|
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | | | 2024 | 67 | 183 |
|
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | | | 2023 | 88 | 135 |
|
| Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients | Clinical infectious diseases | | | 2023 | 106 | 216 |
|
| Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption | Frontiers in oncology | | | 2023 | 75 | 159 |
|
| CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients | Open forum infectious diseases | | | 2023 | 143 | 166 |
|
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | | | 2023 | 72 | 124 |
|
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | | | 2022 | 141 | 374 |
|
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | | 2022 | 266 | 151 |
|
| When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients? | Mycoses | | | 2022 | 105 | 101 |
|
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation | | | 2021 | 354 | 0 |
|
| Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients | Bone marrow transplantation | | | 2021 | 344 | 2 |
|
| Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report | Medicine (Baltimore) | | | 2020 | 396 | 131 |
|
| Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts | Biology of Blood and Marrow Transplantation | | | 2020 | 342 | 315 |
|
| Management of superior vena cava syndrome in critically ill cancer patients | Supportive Care in Cancer | | | 2018 | 362 | 0 |
|
| Success of haploidentical hematopoietic stem cells transplantation in the treatment of graft failure | Annals of Hematology | | | 2016 | 168 | 0 |
|
